Synterex Named 2026 Finalist for U.S. Chamber of Commerce Foundation’s Citizens Awards
BOSTON, MA (September 15, 2026) -- The U.S. Chamber of Commerce Foundation (USCC) has named Synterex, a clinical and regulatory consulting agency serving the life sciences industry, a finalist in the 2026 Citizens Awards. This long-standing program honors impactful businesses for their leadership in solving the world’s biggest challenges. Synterex was nominated for the Best Corporate Steward: Small and Middle-Market Business category.
"Being named a finalist for the Citizens Awards is a tremendous honor,” said Jeanette Towles, President & CEO at Synterex. “This recognition reflects the values that the Synterex team brings to work every day: integrity, collaboration, and a genuine commitment to making a positive impact, both to life science organizations and to the patients they serve.”
The prestigious Best Corporate Steward award is given to “responsive and responsible” companies with exemplary “overall values, operational practices, and decision-making.” Synterex, a woman-owned (WBENC) and disability-owned (DOBE) business, meets the award criteria in multiple ways, such as by providing an award-winning place to work for its 60+ employees and contractors, developing innovative AI-driven solutions for its clients, and reducing its environmental impact through the efforts of its Green Team.
“We're proud to be recognized alongside organizations that share our dedication to corporate citizenship, and we remain committed to raising the bar for what it means to do business responsibly in life sciences,” said Towles.
The winners of the 2026 Citizens Awards will be announced during the U.S. Chamber of Commerce Foundation’s Business Solves Conference on October 27-28.
Learn more about the awards program and register to attend by clicking Featured Events at www.uschamberfoundation.org.
###
About Synterex, Inc.
Synterex is a woman-owned (WBENC) and disability-owned (DOBE) life sciences consulting partner that provides insight through automation, oversight through human experience, and foresight through AI-driven technologies. Since 2016, Synterex has accelerated drug development and solved organizations’ biggest clinical and regulatory challenges by applying adaptive methodologies and deep industry expertise.
Forward-Looking Statements
Certain statements in this press release may be forward-looking, including statements about Synterex’s sustainability initiatives, business priorities, technology-enabled services, and future activities. These statements reflect current expectations and are not guarantees of future performance. Synterex does not undertake any obligation to update these statements, except as required by applicable law.
About the U.S. Chamber of Commerce Foundation
The U.S. Chamber of Commerce Foundation harnesses the power of business to create solutions for the good of America and the world. We anticipate, develop, and deploy solutions to challenges facing communities—today and tomorrow
